Answer
Oczyesa (octreotide) has no or negligible influence on driving ability, but patients should be cautious when driving if they experience dizziness, weakness/fatigue or headache during treatment.
Sources for this answer
- Oczyesa 20 mg prolonged-release solution for injection in pre-filled penCamurus AB · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 2Document updated
Sources checked